BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Current Cash

Track COSCIENS Biopharma's current cash ($9.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.33M
↓ 66.43% YoYΔ $-18.47M vs prior year quarter

Peer average

Loading

COSCIENS Biopharma Current Cash History

Loading

COSCIENS Biopharma vs. peers: Current Cash Comparison

Loading

COSCIENS Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (CSCI) FAQ

As of the most recent data (June 2025), CSCI shows a current cash of $9.3M. That compares with $28M in the prior-year period — down 66.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSCI's current cash is now $9.3M (was $28M) — a 66.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether COSCIENS Biopharma is outperforming or lagging.

Tracking CSCI's current cash over time shows whether COSCIENS Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $28M in the prior-year period — down 66.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has COSCIENS Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $9.3M) with ownership activity and broader fundamentals.